199 related articles for article (PubMed ID: 1795003)
1. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.
Issels RD; Mittermüller J; Gerl A; Simon W; Ortmaier A; Denzlinger C; Sauer H; Wilmanns W
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S141-7. PubMed ID: 1795003
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Issels RD; Prenninger SW; Nagele A; Boehm E; Sauer H; Jauch KW; Denecke H; Berger H; Peter K; Wilmanns W
J Clin Oncol; 1990 Nov; 8(11):1818-29. PubMed ID: 2121910
[TBL] [Abstract][Full Text] [Related]
3. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
[TBL] [Abstract][Full Text] [Related]
4. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
Wessalowski R; Blohm M; Calaminus G; Engert J; Harms D; Krause I; Kruck H; Grüttner HP; Pape H; Göbel U
Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.
Issels RD; Abdel-Rahman S; Wendtner C; Falk MH; Kurze V; Sauer H; Aydemir U; Hiddemann W
Eur J Cancer; 2001 Sep; 37(13):1599-608. PubMed ID: 11527684
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry.
Gellermann J; Hildebrandt B; Issels R; Ganter H; Wlodarczyk W; Budach V; Felix R; Tunn PU; Reichardt P; Wust P
Cancer; 2006 Sep; 107(6):1373-82. PubMed ID: 16902986
[TBL] [Abstract][Full Text] [Related]
7. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Wendtner CM; Abdel-Rahman S; Krych M; Baumert J; Lindner LH; Baur A; Hiddemann W; Issels RD
J Clin Oncol; 2002 Jul; 20(14):3156-64. PubMed ID: 12118030
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia.
Wendtner C; Abdel-Rahman S; Baumert J; Falk MH; Krych M; Santl M; Hiddemann W; Issels RD
Eur J Cancer; 2001 Sep; 37(13):1609-16. PubMed ID: 11527685
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
[TBL] [Abstract][Full Text] [Related]
10. [Regional deep hyperthermia of sarcoma for improving local tumor control].
Issels R
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():923-7. PubMed ID: 1983680
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study.
Angele MK; Albertsmeier M; Prix NJ; Hohenberger P; Abdel-Rahman S; Dieterle N; Schmidt M; Mansmann U; Bruns CJ; Issels RD; Jauch KW; Lindner LH
Ann Surg; 2014 Nov; 260(5):749-54; discussion 754-6. PubMed ID: 25379845
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory continuous infusion ifosfamide with oral etoposide in advanced sarcomas.
Skubitz KM; Hamdan H; Thompson RC
Cancer; 1993 Nov; 72(10):2963-9. PubMed ID: 8221562
[TBL] [Abstract][Full Text] [Related]
14. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Issels RD; Lindner LH; Verweij J; Wust P; Reichardt P; Schem BC; Abdel-Rahman S; Daugaard S; Salat C; Wendtner CM; Vujaskovic Z; Wessalowski R; Jauch KW; Dürr HR; Ploner F; Baur-Melnyk A; Mansmann U; Hiddemann W; Blay JY; Hohenberger P; ;
Lancet Oncol; 2010 Jun; 11(6):561-70. PubMed ID: 20434400
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone.
Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB
J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.
Miser JS; Kinsella TJ; Triche TJ; Tsokos M; Jarosinski P; Forquer R; Wesley R; Magrath I
J Clin Oncol; 1987 Aug; 5(8):1191-8. PubMed ID: 3114435
[TBL] [Abstract][Full Text] [Related]
17. A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Westermann AM; Wiedemann GJ; Jager E; Jager D; Katschinski DM; Knuth A; Vörde Sive Vörding PZ; Van Dijk JD; Finet J; Neumann A; Longo W; Bakhshandeh A; Tiggelaar CL; Gillis W; Bailey H; Peters SO; Robins HI;
Oncology; 2003; 64(4):312-21. PubMed ID: 12759526
[TBL] [Abstract][Full Text] [Related]
18. Dana-Farber Cancer Institute studies in advanced sarcoma.
Antman KH; Elias A
Semin Oncol; 1990 Feb; 17(1 Suppl 2):7-15. PubMed ID: 2106162
[TBL] [Abstract][Full Text] [Related]
19. Ifosfamide with mesna uroprotection and etoposide in recurrent, refractory acute leukemia in childhood. A Pediatric Oncology Group Study.
Bernstein ML; Whitehead VM; Devine S; Grier H; Kung F; Krischer J; Dreyer Z; Bell B; Land V; Buchanan GR
Cancer; 1993 Sep; 72(5):1790-4. PubMed ID: 8348510
[TBL] [Abstract][Full Text] [Related]
20. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]